FDA Okays Gilead Sciences Inc's Zydelig for Blood Cancers

July 24, 2014 9:43 AM

21 0

FDA Okays Gilead Sciences Inc's Zydelig for Blood Cancers

The U.S. Food and Drug Administration said Wednesday that it has okayed Gilead Sciences Inc's Zydelig for treatment of three types of blood cancers.

Zydelig can be used to treat relapsed chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL) and relapsed small lymphocytic lymphoma (SLL).

Read more

To category page

Loading...